300347.SZ · 泰格医药
China A-shares · RS rating 90 · As of 2026-10-14
| Price | 53.07 CNY |
|---|---|
| 1-day change | -2.3% |
| RS rating (overall / 1M / 3M / 12M) | 90 / 92 / 90 / 57 |
| Stage | Topping |
| Composite / Minervini / CANSLIM score | 35 / 43 / 41 |
| Industry group (rank) | Medical-Products (64) |
| EPS growth Q/Q | – |
| Sales growth Q/Q | +5.8% |
| Distance from 52-week high | +20.3% |
| Market cap (USD) | $7.1B |